Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study

In asymptomatic mEGC, immediate start of treatment is preferred by European experts. Consensus was established that treatment can be deferred for patients who prefer deferral and either have a pre-existent WHO/ECOG performance status of 2 or are of advanced age.

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2025-02-01
DOI
https://doi.org/10.1016/j.ejca.2025.115278
Citations
1
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study

Aysegül Ilhan‐Mutlu, Alexander Siebenhüner, Sarah Derks, Radka Obermannová et al.
1 citations
European Journal of Cancer
Lung Cancer Diagnosis and Treatment
1.52
article

Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study

Aysegül Ilhan‐Mutlu, Alexander Siebenhüner, Sarah Derks, Radka Obermannová, Antoine Adenis, Hanneke W.M. van Laarhoven, Alberto Puccini, Giandomenico Roviello, Ana Raimundo, Florian Lordick, Marije Slingerland, Andreia Capela, Nina Fokter Dovnik, Anne M. May, Nadia Haj Mohammad, Angelica Petrillo, Francesca De Felice, D. Kamp, Elizabeth Smyth, Cinta Hierro
article en
1 citations

Abstract

In asymptomatic mEGC, immediate start of treatment is preferred by European experts. Consensus was established that treatment can be deferred for patients who prefer deferral and either have a pre-existent WHO/ECOG performance status of 2 or are of advanced age.

European Journal of CancerVol. 218
Humanitas University (IT), Utrecht University (NL), Masaryk University (CZ), Leiden University Medical Center (NL), Policlinico Umberto I (IT), University Medical Center Utrecht (NL), Klinik Hirslanden (CH), Institut Català d'Oncologia (ES), CUF Porto Hospital (PT), Masaryk Memorial Cancer Institute (CZ), University Clinical Centre Maribor (SI), Institut de Recherche en Cancérologie de Montpellier (FR), Centro Hospitalar de Vila Nova de Gaia (PT), Oxford University Hospitals NHS Trust (GB), Amsterdam University Medical Centers (NL), IRCCS Humanitas Research Hospital (IT), Cancer Center Amsterdam (NL), University of Florence (IT), Medical University of Vienna (AT), Sapienza University of Rome (IT), University of Amsterdam (NL), Leipzig University (DE)
Universitair Medisch Centrum Utrecht, Catharijne Foundation, Wilhelmina Kinderziekenhuis
Good health and well-being
Openalex Percentile: Top 22%
Lung Cancer Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.